The Philippine-California Advanced Research Institutes (PCARI) is a project of the Philippine government’s Commission on Higher Education (CHED) in collaboration with California-based and leading Philippine academic institutions. The PCARI project aims to establish a platform for capacity-building to fulfill the Philippine government’s goal of mobilizing knowledge for greater productivity and economic growth in the areas of Information Infrastructure Development and Health Innovation and Translational Medicine.
Information Infrastructure is the basic, underlying framework of an organization’s information resources. Modern information infrastructure involves both human and technological components. Today, most information is stored, processed and communicated through computers and electronic media. These include the technological and human components, networks, systems, and processes that contribute to the creation, flow or exchange, processing and management of electronic information.
Translational Medicine technically means from “bench-to-bedside” or, from the laboratory to the clinics, hospitals or health centers to address pressing health challenges in the Philippines. Projects in health innovation and translation medicine are expected to involve experts in clinical and translational research, product and technology development, clinical trials, clinical care, and health policy and training.
The University of California-Davis served as a principal collaborator and key partner in the following PCARI projects:
- One Health: Innovations in Early Detection and Interventions in Human, Animal, and Plant Health
- Wearable Cardiac Arrhythmia Monitor Based on Low-Power Radar Principles
- Technology Transfer of Clinical and Molecural Advances in Autism
- Developing Information Infrastructure for Managing Antibiotics and Endocrine Disrupting Substances in Pampanga River Basin and its Coastal Environs: Maps, Transport Models and Bioindicators of Ecological and Public Health Risks
- Glycoproteomics of Filipino Lung Cancer Cell Lines for Biomarker Discovery and Anti-Cancer Screening